Why liquid data is the new liquid gold
By
Companies like Fidelity Investments are creating data assets that are integrated, easily consumable, and ready to be monetized.
By
Companies like Fidelity Investments are creating data assets that are integrated, easily consumable, and ready to be monetized.
By
MIT researchers have developed a methodology for systematically tracking the outcomes of academic licensing transactions as a means of increasing funding to bridging the “valley of death.”
By
A new study led by MIT Sloan Prof. Andrew W. Lo finds that borrowing ideas and tools from the gaming community can improve online teaching techniques and improve learning outcomes for students.
By
Firms that shift to a “domain mindset” can help fill customers’ needs while expanding their own business opportunities.
By
Firms that embrace digital innovation can see value from operations, customers, and becoming a go-to destination in an ecosystem. Kaiser Permanente is one standout.
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
By
Companies whose board members are digitally savvy outperform other companies in areas like revenue growth, return on assets, and market cap growth.
We push the boundaries of finance to solve complex problems and fuel progress in the world through the MIT finance ecosystem – a unique global network of people, programs, research, and partnerships.